Literature DB >> 21439438

Multiple sclerosis genetics 2010.

Joseph P McElroy1, Jorge R Oksenberg.   

Abstract

Multiple sclerosis (MS) is a complex disease involving interactions among multiple genetic loci with modest effects and environment. The human leukocyte antigen (HLA) gene cluster in chromosome 6p21.3 represents by far the strongest MS susceptibility locus genome-wide, with the primary signal arising from the HLA-DRB1gene in the class II segment of the locus. Large, multicenter DNA collections have prospered as the development of new laboratory and analytical approaches has matured at a remarkable pace, allowing the pursuit of comprehensive "agnostic" genome-wide association studies to identify and characterize the non-HLA genetic component of MS. This article summarizes the new knowledge gained from this experimental approach.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21439438     DOI: 10.1016/j.ncl.2010.12.002

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  11 in total

Review 1.  Single nucleotide polymorphisms in multiple sclerosis: disease susceptibility and treatment response biomarkers.

Authors:  Vera Pravica; Dusan Popadic; Emina Savic; Milos Markovic; Jelena Drulovic; Marija Mostarica-Stojkovic
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

2.  Copy number variation in pediatric multiple sclerosis.

Authors:  J P McElroy; L B Krupp; B A Johnson; J L McCauley; Z Qi; S J Caillier; P A Gourraud; J Yu; L Nathanson; A L Belman; S L Hauser; E Waubant; D J Hedges; J R Oksenberg
Journal:  Mult Scler       Date:  2012-12-13       Impact factor: 6.312

Review 3.  Roles for major histocompatibility complex glycosylation in immune function.

Authors:  Sean O Ryan; Brian A Cobb
Journal:  Semin Immunopathol       Date:  2012-03-30       Impact factor: 9.623

4.  Which clinical risk factors determine a pathological urodynamic evaluation in patients with multiple sclerosis? an analysis of 100 prospective cases.

Authors:  A Wiedemann; M Kaeder; W Greulich; H Lax; J Priebel; R Kirschner-Hermanns; I Füsgen
Journal:  World J Urol       Date:  2012-01-07       Impact factor: 4.226

5.  DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).

Authors:  Nathali Kaushansky; Daniel M Altmann; Chella S David; Hans Lassmann; Avraham Ben-Nun
Journal:  J Neuroinflammation       Date:  2012-02-08       Impact factor: 8.322

Review 6.  The genetics of multiple sclerosis: review of current and emerging candidates.

Authors:  Maider Muñoz-Culla; Haritz Irizar; David Otaegui
Journal:  Appl Clin Genet       Date:  2013-08-08

Review 7.  DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele.

Authors:  Nathali Kaushansky; Avraham Ben-Nun
Journal:  Front Oncol       Date:  2014-10-16       Impact factor: 6.244

8.  Heat Shock Protein 70 and The Risk of Multiple Sclerosis in The Iranian Population.

Authors:  Seyedeh Parisa Chavoshi Tarzjani; Seyed Abol Hassan Shahzadeh Fazeli; Mohammad Hossein Sanati; Seyed Massood Nabavi
Journal:  Cell J       Date:  2018-08-01       Impact factor: 2.479

Review 9.  Integration of Biomarkers Into a Signature Profile of Persistent Traumatic Brain Injury Involving Autoimmune Processes Following Water Hammer Injury From Repetitive Head Impacts.

Authors:  Steven Kornguth; Neal Rutledge
Journal:  Biomark Insights       Date:  2018-10-29

10.  Molecular Analysis of rs2070744 and rs1799983 Polymorphisms of NOS3 Gene in Iranian Patients With Multiple Sclerosis.

Authors:  Mohammad Mehdi Heidari; Mehri Khatami; Yaser Tahamtan
Journal:  Basic Clin Neurosci       Date:  2017 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.